Cancer Immunology, Immunotherapy Thistlethwaite, F, Gilham, D, Guest, R, Rothwell, D, Pillai, M, Burt, D, Byatte, A J, Kirillova, N, Valle, J, Sharma, S K, Chester, K A, Westwood, N, Halford, S ER, Nabarro, S, Wan, S, Austin, E & Hawkins, R E 2017, ' The clinical efficacy of first generation carcinoembryonic antigen (CEACAM5) specific CAR T cells is limited by poor persistence and transient pre-conditioning dependent respiratory toxicity ', Cancer Immunology, Immunotherapy . https://doi.org/10.1007/s00262-017-2034-7